These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Why viruses sometimes disperse in groups? Sanjuán R; Thoulouze MI Virus Evol; 2019 Jan; 5(1):vez014. PubMed ID: 31249695 [TBL] [Abstract][Full Text] [Related]
7. Collective Infectious Units in Viruses. Sanjuán R Trends Microbiol; 2017 May; 25(5):402-412. PubMed ID: 28262512 [TBL] [Abstract][Full Text] [Related]
8. Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy. Sewald X Viruses; 2018 Jun; 10(6):. PubMed ID: 29925766 [TBL] [Abstract][Full Text] [Related]
9. Imaging, Tracking and Computational Analyses of Virus Entry and Egress with the Cytoskeleton. Wang IH; Burckhardt CJ; Yakimovich A; Greber UF Viruses; 2018 Mar; 10(4):. PubMed ID: 29614729 [TBL] [Abstract][Full Text] [Related]
10. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. Miller MD; Warmerdam MT; Gaston I; Greene WC; Feinberg MB J Exp Med; 1994 Jan; 179(1):101-13. PubMed ID: 8270859 [TBL] [Abstract][Full Text] [Related]
11. Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors. Jo E; Kim H; König A; Yang J; Yoon SK; Windisch MP Antiviral Res; 2021 Dec; 196():105195. PubMed ID: 34736995 [TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles: Vehicles of en bloc viral transmission. Altan-Bonnet N; Perales C; Domingo E Virus Res; 2019 May; 265():143-149. PubMed ID: 30928427 [TBL] [Abstract][Full Text] [Related]
14. An extension of the Beretta-Kuang model of viral diseases. Siekmann I; Malchow H; Venturino E Math Biosci Eng; 2008 Jul; 5(3):549-65. PubMed ID: 18616358 [TBL] [Abstract][Full Text] [Related]
15. Stochastic theory of early viral infection: continuous versus burst production of virions. Pearson JE; Krapivsky P; Perelson AS PLoS Comput Biol; 2011 Feb; 7(2):e1001058. PubMed ID: 21304934 [TBL] [Abstract][Full Text] [Related]
16. Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents. Mosca JD; Chang YN; Williams G Retrovirology; 2007 May; 4():32. PubMed ID: 17504532 [TBL] [Abstract][Full Text] [Related]